STASI, CRISTINA
 Distribuzione geografica
Continente #
AS - Asia 3.516
NA - Nord America 1.783
SA - Sud America 1.195
EU - Europa 629
Continente sconosciuto - Info sul continente non disponibili 210
AF - Africa 51
OC - Oceania 2
Totale 7.386
Nazione #
US - Stati Uniti d'America 1.631
VN - Vietnam 1.060
BR - Brasile 921
HK - Hong Kong 704
SG - Singapore 693
IT - Italia 349
KR - Corea 316
CN - Cina 304
BD - Bangladesh 289
AR - Argentina 108
FR - Francia 82
CA - Canada 66
DE - Germania 57
MX - Messico 53
ID - Indonesia 52
EC - Ecuador 51
GB - Regno Unito 42
CO - Colombia 29
RU - Federazione Russa 28
CL - Cile 27
IN - India 19
PY - Paraguay 19
ZA - Sudafrica 19
NL - Olanda 17
PE - Perù 16
IQ - Iraq 15
VE - Venezuela 15
PL - Polonia 14
UA - Ucraina 14
AZ - Azerbaigian 9
EG - Egitto 9
HN - Honduras 8
MA - Marocco 8
PK - Pakistan 8
UZ - Uzbekistan 8
UY - Uruguay 7
AE - Emirati Arabi Uniti 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
ES - Italia 4
FI - Finlandia 4
JP - Giappone 4
KE - Kenya 4
LB - Libano 4
MY - Malesia 4
PR - Porto Rico 4
TR - Turchia 4
AM - Armenia 3
GT - Guatemala 3
HU - Ungheria 3
KZ - Kazakistan 3
NI - Nicaragua 3
SN - Senegal 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
DZ - Algeria 2
HR - Croazia 2
IE - Irlanda 2
JM - Giamaica 2
NP - Nepal 2
OM - Oman 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
LT - Lituania 1
MK - Macedonia 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.177
Città #
Hong Kong 704
Ho Chi Minh City 432
Ashburn 328
Seoul 315
Singapore 258
Hanoi 239
San Jose 164
Chicago 147
Dallas 144
New York 118
Los Angeles 105
São Paulo 78
Beijing 59
Rome 49
Florence 47
Haiphong 39
San Francisco 39
Rio de Janeiro 36
Orem 35
Denver 34
Santa Clara 34
Da Nang 32
Atlanta 30
Biên Hòa 30
Mexico City 30
Montreal 27
Curitiba 25
Phoenix 25
Munich 24
Milan 23
Hải Dương 20
Brooklyn 19
Bắc Giang 18
Lauterbourg 18
Bắc Ninh 17
Buffalo 16
Guayaquil 16
Toronto 16
Brasília 15
Düsseldorf 15
Frankfurt am Main 15
Hillsboro 15
Seattle 15
Goiânia 13
Phủ Lý 13
Porto Alegre 13
Houston 12
Hưng Yên 12
Lima 12
London 12
Naples 12
Ninh Bình 12
Quito 12
Belo Horizonte 11
Bình Dương 11
Jakarta 11
Thái Bình 11
Campinas 10
Asunción 9
Baku 9
Guarulhos 9
Hòa Bình 9
Ribeirão Preto 9
Can Tho 8
Ha Long 8
Santiago 8
Vancouver 8
Boston 7
Caracas 7
Johannesburg 7
Medellín 7
Milwaukee 7
Osasco 7
Tashkent 7
Thái Nguyên 7
Bari 6
Buenos Aires 6
Dhaka 6
Duque de Caxias 6
Huế 6
Messina 6
Miami 6
Pittsburgh 6
Portsmouth 6
Recife 6
Sorocaba 6
São Gonçalo 6
Taboão da Serra 6
Turin 6
Wroclaw 6
Araçatuba 5
Bauru 5
Betim 5
Bexley 5
Cachoeirinha 5
Canary Wharf 5
Canoas 5
Catania 5
Caxias do Sul 5
Charleston 5
Totale 4.315
Nome #
Sexual Behavior and Awareness of Sexually Transmitted Diseases among Street-Based Female Sex Workers in the Florence Area, Central Italy 860
Recensione del libro di M.D. Gershon. Il secondo cervello. UTET- Torino 2005 104
The Epidemiology of Chronic Hepatitis C: Where We Are Now 90
Evaluation of latent links between irritable bowel syndrome and sleep quality 76
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 71
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model 71
Morbidity risk in an Italian cohort of HBV and HCV patients. 67
Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play? 65
Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany 63
Hepatitis C Virus Opportunistic Screening in South-Eastern Tuscany Residents Admitted to the University Hospital in Siena 63
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemic 59
Evaluation of serotonin transporter in patients with irritable bowel syndrome both before and after treatment with alosetron 59
Prevalence and features of chronic viral hepatitis and HIV/viral hepatitis coinfections in Italian prisons 58
COVID-19’s Impact on psychological disorders, gastrointestinal and liver diseases 58
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany. 57
Response to IFN-based antiviral therapy and long term effect of HCV eradication in Mixed Cryoglobulinemia, with or without symptoms: a prospective, controlled, open-label, long term, cohort study 57
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 56
Early Warning Approach to Identify Positive Cases of SARS-CoV-2 in School Settings in Italy 55
Access to SARS-CoV-2 vaccination in immigrants in Italy, by geographical area of origin 54
Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness 54
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 53
Hepatitis B virus screening and accelerated vaccination program in prison: A multicentre pilot study 52
Assessment of liver fibrosis stage in PBC 52
Imaging modalities for the noninvasive assessment of fibrosis in Crohn's disease 52
Assessment of Free Light Chains in HCV positive patients undergoing Rituximab treatment. 51
Assessment of liver stiffness in patients with HCV-related mixed cryoglobulinemia undergoing rituximab treatment 51
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome 51
Prospective evaluation of the effects of GLP1 receptor agonists and SGLT2 inhibitors in MASLD patients with type 2 diabetes 51
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 51
Bimodal rehabilitation of the pelvic floor dyssynergia: fact or fiction? 51
Emerging trends in epidemiology of hepatitis b virus infection 50
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis 49
Italian guidelines for the management of irritable bowel syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP). 49
Correlation between indirect serum markers and morphometric values of fibrotic tissue in PBC 49
Genetic and B-cell clonality markers in HCV-related cryoglobulinemic vasculitis persisting after DAA therapy 48
The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes 48
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment 48
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia 47
Comparison and correlation of fibrosis stage assessment by collagen proportionate area (CPA) and the ELF panel in patients with chronic liver disease 47
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome 47
Evolving strategies for liver fibrosis staging: Non-invasive assessment 47
DRESS syndrome in a patient with chronic hepatic encephalopathy 47
Post-COVID-19 Pandemic Sequelae in Liver Diseases 47
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 47
Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis 46
LA SALUTE DEI DETENUTI IN ITALIA: i risultati di uno studio multicentrico 45
Viral kinetics in patients with chronic hepatitis B treated with combination therapy with PEG-IFN and nucleoside analogues 45
Malattie Infettive 45
Increased levels of neuropeptide Y in patients with irritable bowel sindrome 45
Epidemiologia dell’infezione cronica da HCV in Toscana. Rapporto, Luglio, 2017 45
An extended assessment of bowel habits in a general population 45
Crohn’s disease and psychological disorders 44
Safety and effectiveness of boceprevir triple therapy in patients with mixed cryoglobulinemia 44
Prevalenza e caratteristiche delle epatiti virali croniche e di altre malattie infettive nelle strutture detentive in Italia 44
Acute viral hepatitis increases liver stiffness values measured by transient elastography 44
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 44
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 43
Assessment of liver fibrosis in primary biliary cholangitis: Comparison between indirect serum markers and fibrosis morphometry 43
New Treatment Options for MASLD Patients with Type 2 Diabetes 43
Liver Stiffness Evaluation in Chronic Hepatitis C Patients with Cirrhosis before and after Direct-Acting Antivirals 43
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients. 42
Prevalenza delle epatiti virali croniche e della sindrome da immunodeficienza acquisita in una coorte urbana in Toscana (Italy). 42
Radionuclide gastroesophageal motor studies 42
Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis 42
The relationship between the serotonin metabolism, gut-microbiota and the gut-brain axis 42
HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective study 41
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders 41
Evaluation of latent links between irritable bowel syndrome and sleep quality 41
Il modello della pelle biologica per la costruzione della identità psichica 40
Prevalenza e caratteristiche dei pazienti HIV con coinfezioni da virus delle epatiti croniche B e C in Toscana 40
IBS clinical management in Italy: The AIGO survey 40
Malattie infiammatorie croniche intestinali. Il morbo di Crohn nel modello psiconeuroendocrinologico. 40
Could lactoferrin and probiotics improve Helicobacter Pylori eradication rate and reduce side effects of triple standard therapy? 40
Epatiti virali 40
Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination 40
Attempt to calculate the prevalence and features of chronic hepatitis C infection in Tuscany using administrative data 39
Opportunistic screening for Hepatitis C Virus infection among hospitalized patients at the University Hospital in Siena 39
Epatite acuta a eziologia sconosciuta in età pediatrica 39
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment 39
Psiconeuroimmunoendocrinologia nel morbo di Crohn 38
La salute mentale della popolazione detenuta: la situazione italiana emersa da uno studio multicentrico 38
Uncoupling of the hypothalamic-pituitary-adrenal and hypothalamic-autonomic nervous system axes in irritable bowel syndrome 38
Gastrointestinal manifestations in myotonic muscular dystrophy 38
Treatment for COVID-19: An overview 38
An attempt to define the aetiology of liver cirrhosis mortality in Tuscany 38
Self-perceived normality in defecation habits 38
Longitudinal evaluation of liver stiffness and outcomes in patients with chronic hepatitis C before and after short- and long-term IFN-free antiviral treatment 38
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 38
La Rettocolite Ulcerosa nel concetto di Somatopsicosi 37
Lo stato di salute dei detenuti italiani 37
The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials 37
Il calcolo della prevalenza dell'epatite cronica C attraverso i dati amministrativi: il tentativo toscano 37
Il seno: aspetti fisiopatologici e psicodinamici 36
SARS-CoV-2 was already circulating in Italy, in early December 2019 36
Infectious diseases in the Tuscan detention setting: Data from the Health Agency of Tuscany 36
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 36
The general practitioner's approach to irritable bowel syndrome: from intention to practice 36
The epidemiological changes of HCV and HBV infection in the era of the new antiviral therapy and anti-HBV vaccine 36
Irritable bowel syndrome and chronic constipation: Fact and fiction 36
Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results 36
Totale 5.537
Categoria #
all - tutte 43.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.891 0 0 0 0 0 0 0 0 130 1.392 318 51
2025/20264.487 321 185 855 1.079 346 49 54 302 410 262 386 238
2026/20271.008 897 111 0 0 0 0 0 0 0 0 0 0
Totale 7.386